On June 11, The New York Times reported that US health officials were forced to throw away about 60 million doses of a single-injection vaccine of Johnson & Johnson (J&J) due to a contamination incident at the manufacturing plant. they’re in Baltimore.
According to the report, the US Food and Drug Administration (FDA) said that in addition, 10 million other doses of this plant’s vaccines will be distributed, but the agency cannot guarantee that they are produced. export according to the correct safety procedures.
The FDA has not yet decided whether to reopen the plant, currently operated by Emergent BioSolutions.
|Federal regulators are forcing Johnson & Johnson to discard about 60 million doses of the Covid-19 vaccine because of contamination.|
Having to throw away 60 million doses of the COVID-19 vaccine at this time is the latest setback for Emergent BioSolutions, which has been under scrutiny for months after a cross-contamination incident in a component of the vaccine. AstraZeneca vaccine with one component of the J&J vaccine. Subsequent delays prevented millions of doses of the J&J vaccine from being delivered to vaccination facilities.
Meanwhile, hospitals, state health departments and the US federal government are also scrambling to figure out what to do with the millions of doses of the J&J vaccine that are about to expire this June.
The WSJ explained that the millions of doses of J&J vaccine in stock were due to a short period of time when the vaccine was discontinued due to concerns about blood clotting. Many J&J vaccine applicants have canceled their appointments even after vaccinations resumed.
This newspaper also said that the prospect of these vaccines having to be destroyed while developing countries do not have vaccines to vaccinate them puts more pressure on the administration of President Joe Biden to immediately share these vaccines with others. countries as soon as possible. However, how to be able to transfer these vaccines to countries quickly and promptly before the expiration date is not easy.
Data from the US Centers for Disease Control and Prevention (CDC) shows that more than 10 million doses of the J&J vaccine are about to expire across the country.
The state of Philadelphia currently has 42,000 doses of the expired J&J vaccine, and states like West Virginia, Oklahoma, Ohio and Arkansas are also stocking thousands of doses of the soon-to-be-expired J&J vaccine. Meanwhile, a fairly large number of two other US vaccines, Pfizer/BioNTech and Moderna, are also about to expire in the next few months because the shelf life of the vaccines is six months.
In order to quickly deal with the above vaccines, many hospitals and medical facilities in the US states have had to offer incentives in the hope that more people will accept the J&J vaccine before the number of vaccines. This expires. However, these efforts have not yielded much success because the vaccination process in the United States has begun to slow down.
According to the US CDC, the US has only used up more than half of the total 21.4 million doses of J&J vaccine allowed for circulation, but has used up 83% of the manufactured Pfizer/BioNTech and Moderna vaccines.
The World Health Organization says 11 billion doses of vaccine are needed globally to help prevent the pandemic from getting worse. The United States is buying 500 million doses of the two-shot Pfizer vaccine to distribute to countries in need, President Joe Biden is expected to announce at G7 meetings this weekend.